The KPMG report, *Board Oversight of GenAI: Business Values, Guardrails and Governance*, guides corporate boards on effectively overseeing generative AI. As GenAI transitions from experimentation to enterprise-wide use, boards must balance accelerating opportunities with managing risks. While C-suites focus on innovation and new revenue, directors emphasize operating efficiency and risk mitigation. The report outlines key board priorities: understanding GenAI’s evolving capabilities, ensuring responsible deployment with robust governance, assessing risks including data quality and cybersecurity, and aligning leadership. Boards are encouraged to probe management on strategic goals, risk frameworks, and investment plans.

Join for free to read